SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-058937
Filing Date
2020-03-02
Accepted
2020-03-02 16:21:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d871731d424b5.htm 424B5 485129
2 GRAPHIC g871731g99d28.jpg GRAPHIC 62588
  Complete submission text file 0001193125-20-058937.txt   572478
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-236639 | Film No.: 20677121
SIC: 2834 Pharmaceutical Preparations